Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Fine-tuning p53 activity through C-terminal modification significantly contributes to HSC homeostasis and mouse radiosensitivity.

Genes & development | Jul 1, 2011

Cell cycle regulation in hematopoietic stem cells (HSCs) is tightly controlled during homeostasis and in response to extrinsic stress. p53, a well-known tumor suppressor and transducer of diverse stress signals, has been implicated in maintaining HSC quiescence and self-renewal. However, the mechanisms that control its activity in HSCs, and how p53 activity contributes to HSC cell cycle control, are poorly understood. Here, we use a genetically engineered mouse to show that p53 C-terminal modification is critical for controlling HSC abundance during homeostasis and HSC and progenitor proliferation after irradiation. Preventing p53 C-terminal modification renders mice exquisitely radiosensitive due to defects in HSC/progenitor proliferation, a critical determinant for restoring hematopoiesis after irradiation. We show that fine-tuning the expression levels of the cyclin-dependent kinase inhibitor p21, a p53 target gene, contributes significantly to p53-mediated effects on the hematopoietic system. These results have implications for understanding cell competition in response to stresses involved in stem cell transplantation, recovery from adverse hematologic effects of DNA-damaging cancer therapies, and development of radioprotection strategies.

Pubmed ID: 21724834 RIS Download

Mesh terms: Animals | Cells, Cultured | Cyclin-Dependent Kinase Inhibitor p21 | Female | Gamma Rays | Gene Dosage | Gene Expression Regulation | Gene Knock-In Techniques | Hematopoietic Stem Cells | Homeostasis | Longevity | Male | Mice | Mice, Inbred C57BL | Mutation | Proto-Oncogene Proteins c-mdm2 | Radiation Tolerance | Tumor Suppressor Protein p53

Research resources used in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, Id: CA094056
  • Agency: NCI NIH HHS, Id: P50 CA094056
  • Agency: NCI NIH HHS, Id: CA100845
  • Agency: NCI NIH HHS, Id: U01 CA84244
  • Agency: NCI NIH HHS, Id: R01 CA100845
  • Agency: NCI NIH HHS, Id: CA61449
  • Agency: NCI NIH HHS, Id: 5P30CA014195
  • Agency: NCI NIH HHS, Id: R01 CA061449
  • Agency: NCI NIH HHS, Id: U01 CA084244
  • Agency: NCI NIH HHS, Id: P30 CA014195

Mouse Genome Informatics (Data, Gene Annotation)

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.

Salk Institute Razavi Newman Integrative Genomics and Bioinformatics Core Facility (IGC)

Core facility established to assist the Salk community with integrating genomics data into their research. The primary focus of the core is to provide analysis support for next-generation sequencing applications.


View all literature mentions